Hypoxia-inducible factor and vascular endothelial growth factor in the neuroretina and retinal blood vessels after retinal ischemia

Journal of Ocular Biology, Diseases, and Informatics

Volumn 3, Issue 1, 2010, Pages 20-29

  Håkansson, Gisela ^a   Gesslein, Bodil ^a   Gustafsson, Lotta ^a   Englund Johansson, Ulrica ^a   Malmsjö, Malin ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Blood vessels; Hypoxia inducible factor; Ischemia; Porcine; Retina; Vascular endothelial growth factor

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOLOGY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETINA BLOOD VESSEL; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETINA NERVE CELL; SWINE; VITREOUS BODY;

SUS;

EID: 78650213172     PISSN: None     EISSN: 19368445     Source Type: Journal    
DOI: 10.1007/s12177-010-9050-6     Document Type: Article

References (27)

1. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23(1):91-147.
2. Curtis TM, Scholfield CN. The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy. Diabetes Metab Res Rev. 2004;20(1):28-43.
3. Dorrell M, Uusitalo-Jarvinen H, Aguilar E, Friedlander M. Ocular neovascularization: basic mechanisms and therapeutic advances. Surv Ophthalmol. 2007;52 Suppl 1: S3-19.
4. Comer GM, Ciulla TA. Pharmacotherapy for diabetic retinopathy. Curr Opin Ophthalmol. 2004;15(6):508-18.
5. Hessellund A, Jeppesen P, Aalkjaer C, Bek T. Characterization of vasomotion in porcine retinal arterioles. Acta Ophthalmol Scand. 2003;81(3):278-82. (Pubitemid 36806267)
6. Holmgaard K, Aalkjaer C, Lambert JD, Bek T. N-methyl-D-aspartic acid causes relaxation of porcine retinal arterioles through an adenosine receptor dependent mechanism. Invest Ophthalmol Vis Sci. 2008;49(10):4590-4.
7. Nagaoka T, Hein TW, Yoshida A, Kuo L. Resveratrol, a component of red wine, elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels. Invest Ophthalmol Vis Sci. 2007;48(9):4232-9. (Pubitemid 351261054)
8. Chavez A, Miranda LF, Pichiule P, Chavez JC. Mitochondria and hypoxia-induced gene expression mediated by hypoxia-inducible factors. Ann N y Acad Sci. 2008;1147:312-20.
9. Ozaki H, Yu AY, Della N, Ozaki K, Luna JD, Yamada H, et al. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci. 1999;40(1):182-9.
10. Zhu Y, Zhang Y, Ojwang BA, Brantley Jr MA, Gidday JM. Long-term tolerance to retinal ischemia by repetitive hypoxic preconditioning: role of HIF-1alpha and heme oxygenase-1. Invest Ophthalmol Vis Sci. 2007;48(4):1735-43.
11. Weinberg RA. Biology of cancer. London: Taylor & Francis; 2006.
12. Arjamaa O, Nikinmaa M. Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp Eye Res. 2006;83(3):473-83.
13. Thiersch M, Raffelsberger W, Frigg R, Samardzija M, Wenzel A, Poch O, et al. Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuro-protection. BMC Genomics. 2008;9:73.
14. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331(22):1480-7.
15. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A. 1995;92(3):905-9.
16. Buckley CH, Hadoke PW, O'Brien CJ. Use of isolated ocular arteries in vitro to define the pathology of vascular changes in glaucoma. Br J Ophthalmol. 1997;81(7):599-607.
17. Rootman J. Vascular system of the optic nerve head and retina in the pig. Br J Ophthalmol. 1971;55(12):808-19.
18. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, editor. Bioinfor-matics methods and protocols: methods in molecular biology. Totowa: Humana; 2000. p. 365-86.
19. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 2000;25(2):169-93.
20. Abràmoff MD, Magelhaes PJ, Ram SJ. Image Processing with ImageJ. Biophotonics Int. 2004;11(7):36-42.
21. Bignami A, Dahl D. The radial glia of Muller in the rat retina and their response to injury. An immunofluorescence study with antibodies to the glial fibrillary acidic (GFA) protein. Exp Eye Res. 1979;28(1):63-9.
22. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, et al. Muller cells in the healthy and diseased retina. Prog Retin Eye Res. 2006;25(4):397-424.
23. Iandiev I, Uckermann O, Pannicke T, Wurm A, Tenckhoff S, Pietsch UC, et al. Glial cell reactivity in a porcine model of retinal detachment. Invest Ophthalmol Vis Sci. 2006;47(5):2161-71.
24. Kim HA, Mahato RI, Lee M. Hypoxia-specific gene expression for ischemic disease gene therapy. Adv Drug Deliv Rev. 2009;61:614-22.
25. Yi JH, Park SW, Kapadia R, Vemuganti R. Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochem Int. 2007;50(7-8): 1014-27.
26. Ziello JE, Jovin IS, Huang Y. Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med. 2007;80(2):51-60.
27. Forooghian F, Razavi R, Timms L. Hypoxia-inducible factor expression in human RPE cells. Br J Ophthalmol. 2007;91(10):1406-10.